Pages
Subscribe to my blog
-
Recent Blog Posts
- COVID-19 Vaccines: Talks to U3A Melbourne City
- Complementary medicines weight loss complaints submitted to the TGA in 2018-2019. Follow-up in February 2021.
- Unnecessary, expensive and potentially dangerous supplements consumed by older Australians
- Resignation from TGACC
- Independent Review of the Therapeutic Goods Advertising Framework: Recommendations
- Complementary medicine weight loss products complaints submitted to the TGA in 2018-2019. Follow-up July 2020
Themes
- ABC
- ACCC
- advertisments
- AHPRA
- AMHC
- AMI
- ARTG
- Blackmores
- Chiropractic Board
- Complaint Resolution Panel
- Complementary Medicines
- consumers
- CRP
- Dr Tom Goyer
- food-medicine interface
- FSANZ
- FSM
- Geoff Jowett
- Health Practitioner Regulation National Law Act
- health professionals
- homeopathic medicines
- Ian Rossborough
- La Trobe University
- Medical Weightloss Institute
- Medicines Australia
- MMD Review
- Monash University
- MWI
- Pharmacare Laboratories
- promotion
- Regulatory Reform
- self-regulation
- Senate Community Affairs Legislation Committee
- Souvenaid
- Swisse
- Swisse Vitamins
- TGA
- TGACC
- TGA Complaint system
- TGACRP
- Therapeutic Goods Act
- Therapeutic Goods Advertising Code
- Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017
- Transparency
- U3A
Archives
- February 2021
- November 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- October 2019
- September 2019
- August 2019
- July 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- January 2015
- December 2014
- November 2014
- October 2014
- July 2014
- March 2014
- February 2014
- January 2014
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- May 2012
- April 2012
- March 2012
- June 2011
Subscribe2
Tag Archives: TGACC
Resignation from TGACC
My resignation from the Therapeutic Goods Advertising Consultative Committee (TGACC) was precipitated by the non-response of Adj Professor John Skerritt, Deputy Secretary, Health Products Regulation Group, Department of Health, to long-standing issues raised yet again at the Skepticon 2020 regulatory … Continue reading
TGA provides complementary medicine industry with “Get Out of Jail Free card”
The TGA have recently given approval (under section 42DF of the Therapeutic Goods Act 1989) for a restricted advertising representation by The Tomato Pill Company for Ateronon XY Pro: “Saw Palmetto is traditionally used in herbal medicine to help relieve the … Continue reading
Posted in Complementary medicine, Natural Therapies, Pharmaceutical Promotion
Tagged AHPRA, Ateronon XY Pro; Go Vita; Restricted representation approval; traditional use; s.133 National Law, Complaint Resolution Panel, Dr Ross Walker, Senate Standing Committees on Community Affairs, TGA, TGA funding, TGACC, Therapeutic Goods Advertising Code, Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017, Tomato Pill Company
1 Comment
TGA Consultation Submissions: Regulatory reform of complementary medicines and advertising
The regulatory framework for advertising therapeutic goods Reforms to the regulatory framework for complementary medicines – assessment pathways Options for the future regulation of “low-risk” products Draft List of Permitted Indications Therapeutic Goods Advertising Code See also: Australian patients vulnerable … Continue reading
TGA has lost trust on CMS: Harvey
“a market flooded with shonky products and unethical claims” Open debate needed for TGA to regain trust TGA has lost trust on CMs: Harvey by
Bizarre advertising approval by TGA
The TGA can only grant advertising approval for a restricted representation if the representation is accurate, balanced, not misleading and in the public interest. The TGA has now approved restricted representations for two probiotic products: Puremedic Pty Ltd (9 June 2016); … Continue reading
Posted in Pharmaceutical Promotion
Tagged Homeopathy, Mastitis, Nutricia, Probiotics, Profutura, Puremedic, Qiara, Restless legs, TGA, TGACC
Leave a comment
TGA failure gives Nurofen consumers a headache
http://theconversation.edu.au/tga-failure-gives-nurofen-consumers-a-headache-8762 by